Winslow Evans & Crocker Inc. Increases Stake in Tiffany & Co. (TIF)

Winslow Evans & Crocker Inc. increased its stake in shares of Tiffany & Co. (NYSE:TIF) by 161.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,753 shares of the specialty retailer’s stock after buying an additional 1,699 shares during the period. Winslow Evans & Crocker Inc.’s holdings in Tiffany & Co. were worth $260,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Fifth Third Bancorp raised its position in Tiffany & Co. by 6.0% in the first quarter. Fifth Third Bancorp now owns 1,090 shares of the specialty retailer’s stock valued at $104,000 after buying an additional 62 shares during the period. IFP Advisors Inc raised its position in Tiffany & Co. by 66.9% in the first quarter. IFP Advisors Inc now owns 1,237 shares of the specialty retailer’s stock valued at $118,000 after buying an additional 496 shares during the period. Macquarie Group Ltd. raised its position in Tiffany & Co. by 325.0% in the fourth quarter. Macquarie Group Ltd. now owns 1,700 shares of the specialty retailer’s stock valued at $132,000 after buying an additional 1,300 shares during the period. Advisory Services Network LLC bought a new position in Tiffany & Co. during the first quarter valued at approximately $133,000. Finally, Welch Group LLC raised its position in Tiffany & Co. by 0.6% in the first quarter. Welch Group LLC now owns 1,541 shares of the specialty retailer’s stock valued at $147,000 after buying an additional 9 shares during the period. 81.01% of the stock is owned by institutional investors.

Tiffany & Co. (NYSE:TIF) opened at 91.90 on Monday. Tiffany & Co. has a 52 week low of $58.76 and a 52 week high of $97.29. The firm’s 50-day moving average price is $91.35 and its 200-day moving average price is $87.67. The company has a market capitalization of $11.46 billion, a price-to-earnings ratio of 25.51 and a beta of 1.92.

Tiffany & Co. (NYSE:TIF) last released its earnings results on Wednesday, May 24th. The specialty retailer reported $0.74 EPS for the quarter, topping analysts’ consensus estimates of $0.70 by $0.04. Tiffany & Co. had a net margin of 11.26% and a return on equity of 15.91%. The firm had revenue of $899.60 million during the quarter, compared to analyst estimates of $915.48 million. During the same quarter in the previous year, the business earned $0.64 EPS. The business’s quarterly revenue was up .9% compared to the same quarter last year. On average, equities analysts expect that Tiffany & Co. will post $3.96 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Monday, July 10th. Shareholders of record on Tuesday, June 20th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.18%. The ex-dividend date was Friday, June 16th. This is a positive change from Tiffany & Co.’s previous quarterly dividend of $0.45. Tiffany & Co.’s payout ratio is currently 55.56%.

TRADEMARK VIOLATION WARNING: This piece was reported by Ticker Report and is the property of of Ticker Report. If you are accessing this piece on another site, it was copied illegally and republished in violation of United States and international copyright and trademark law. The original version of this piece can be accessed at https://www.tickerreport.com/banking-finance/2722297/winslow-evans-crocker-inc-increases-stake-in-tiffany-co-tif.html.

Several equities analysts have recently commented on the company. Goldman Sachs Group, Inc. (The) reaffirmed a “buy” rating and set a $104.00 target price on shares of Tiffany & Co. in a report on Thursday, June 1st. Telsey Advisory Group lowered their target price on Tiffany & Co. from $110.00 to $93.00 and set an “outperform” rating for the company in a report on Monday, March 20th. Bank of America Corporation reaffirmed a “buy” rating and set a $110.00 target price on shares of Tiffany & Co. in a report on Wednesday, May 10th. Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $88.00 target price (down from $93.00) on shares of Tiffany & Co. in a report on Thursday, May 25th. Finally, Jefferies Group LLC reaffirmed a “buy” rating and set a $110.00 target price on shares of Tiffany & Co. in a report on Tuesday, May 2nd. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $92.36.

About Tiffany & Co.

Tiffany & Co is a holding company that operates through its subsidiary companies. The Company’s principal subsidiary, Tiffany and Company (Tiffany), is a jeweler and specialty retailer. The Company’s segments include Americas, Asia-Pacific, Japan, Europe and Other. Through its subsidiaries, the Company designs and manufactures products and operates TIFFANY & CO.

Want to see what other hedge funds are holding TIF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tiffany & Co. (NYSE:TIF).

Institutional Ownership by Quarter for Tiffany & Co. (NYSE:TIF)

Receive News & Ratings for Tiffany & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tiffany & Co. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
Shares at Radius Jump as Bone Drug of Amgen Has Setback
Shares at Radius Jump as Bone Drug of Amgen Has Setback


Leave a Reply

© 2006-2017 Ticker Report. Google+.